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Abstract
South Korea is one of many countries with endemic Plasmodium vivax malaria. Here we report the evaluation of four rapid
diagnostic tests (RDTs) for diagnosis of this disease. A total of 253 subjects were enrolled in the study. The sensitivities,
specificities and agreement frequencies were estimated by comparing the four RDTs against the standard of nested-PCR
and microscopic examination. The CareStartTM and SD Bioline had higher test sensitivities (99.4 and 98.8%, respectively)
compared with the NanoSign and Asan Easy tests (93.0 and 94.7%, respectively). The CareStartTM and SD Bioline tests could
detect P. vivax in samples with parasite densities,150/ml, which was a slightly better performance than the other two RDTs.
The quantitative accuracy of the four RDTs was also estimated by comparing results with P. vivax counts from blood
samples. Lower test price would result in increased use of these RDTs in the field. The results of this study contribute
valuable information that will aid in the selection of a diagnostic method for the detection of malaria.
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Introduction
Worldwide, Plasmodium vivax accounts for an estimated 80
million cases of malaria each year [1]. P. vivax is the only
indigenous Plasmodium species in South Korea. Vivax malaria has
been endemic in Korea and seasonal transmission has occurred
since the disease re-emerged in 1993. From 1994 to 2010, 29,692
cases of endemic vivax malaria were reported. South Korea has
embarked on a malaria elimination program based on early and
accurate diagnosis followed by radical and rapid treatment.
Standardization and use of sensitive diagnostic tools are critically
important for a successful program outcome.
During the last 100 years, malaria has been diagnosed by
microscopic examination of Giemsa-stained thick and thin blood
films [2,3] and today this approach is the gold standard for malaria
diagnosis that is recommended by the World Health Organization
(WHO). However, microscopy performed by poorly trained
personnel that live in the rural areas of endemic malaria has a
low sensitivity [4,5]. This limitation has prompted research and
development of reliable, easy to perform, rapid tests such as Rapid
Diagnostic Test (RDT) to detect the presence of malaria parasites
at levels of accuracy comparable to skilled microscopists. RDTs
use immunochromatographic techniques to identify Plasmodium
antigens. RDT performance is affected by the target antigen [6,7].
RDTs are being used to diagnose vivax malaria in field studies
[8,9], as an alternative to microscopy at health facilities where
quality microscopy is not available. Indeed, diagnosticians depend
on RDTs for malaria diagnosis in endemic regions and in soldiers
of Korean armed forces.
RDT performance varies with the environment of employment,
geographical location, disease prevalence, and parasite species.
RDT sensitivity declines with low parasite densities (,300–500/
ml) [9,10]. To address this problem, WHO collaborated with the
Foundation for Innovative New Diagnostics (FIND) to systemat-
ically compare the laboratory performance of RDTs. Four rounds
of testing have been published (http://www.finddiagnostics.org/
resource-centre/reports_brochures/malaria-diagnostic-test-report.
html). Interestingly, some field test results have differed from the
laboratory results reported by WHO/FIND [11], which highlights
the importance of testing RDTs in different environments. For
example, WHO/FIND reported good performance for the Opti-
MAL rapid malaria test, but the test performed significantly worse
in a Thailand study [12]. From 2009 to 2011, we evaluated the
performance of four RDTs at the National Laboratory, Korea.
Three of the RDTs (SD Bioline, NanoSign and Asan Easy) are
produced in South Korea and one test (CareStartTM) is produced
in the United States. The SD Bioline and CareStartTM tests
performed well in the WHO/FIND comparison [13,14]. A total of
171 fresh blood samples from patients diagnosed with vivax
malaria at local health centers (2009–2011), and 82 blood samples
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from asymptomatic and aparasitemic healthy volunteers were used
in this evaluation. RDT performance was compared to micro-
scopic examination and nested PCR. The accuracy of each RDT
for the quantification of parasite density was also investigated.
Materials and Methods
Ethics statements
The study was approved by the ethics committee of the Korean
National Institute of Health. An approval form was used to obtain
written informed consent from each participant. Each participant
also gave permission to provide a 5 ml blood sample.
Sample collection
The study was conducted at the Division of Malaria and
Parasitic Diseases, the Korea Centers for Disease Control and
Prevention (KCDC), from June 2009–October 2011. Venous
blood samples with EDTA were received from 171 patients
diagnosed with vivax malaria at local health centers (Kang-wha,
Paju, Gimpo, Yeon-Cheon; Fig. 1). Microscopic examination of
Giemsa-stained thick and thin blood films was used to confirm the
diagnosis. Samples were also received from 82 asymptomatic and
aparasitemic healthy volunteers, which had been confirmed as P.
vivax negative by microscopic examination and nested-PCR. Mean
age of the patients was 47 years, and 75% of them were male.
Blood specimens were kept cool and arrived at the KCDC within
24 hours after collection.
Characterization of rapid diagnostic tests
All blood samples were assayed with each of four commercial
RDTs. CareStartTM Malaria HRP/pLDH (Access Bio, USA)
detected parasite antigen PfHRP-2 specific for P. falciparum in one
capture site and pan-pLDH, which detected all four Plasmodium
species, in a separate capture line. Individually packed test
cassettes and fixed quantified sample buffer in a disposable tube
were provided in each package of tests.
SD Bioline Ag P.f/pan Rapid (SD, Korea), also in individually
packed test cassettes, detected parasite antigen PfHRP-2 using a
Figure 1. Sample selection profile for the evaluation of four rapid diagnostic tests. Microscopic examination, nested-PCR, and rapid
diagnostic tests were performed.
doi:10.1371/journal.pone.0064353.g001
Table 1. Performance of four rapid diagnostic tests when compared with microscopic examination for Plasmodium vivax malaria
diagnosis.
Microscopic
examination (n) Nested-PCR CareStart
TM SD Bioline NanoSign Asan Easy
Positive
(%)
Negative
(%)
Positive
(%)
Negative
(%)
Positive
(%)
Negative
(%)
Positive
(%)
Negative
(%)
Positive
(%)
Negative
(%)
Positive (171) 171(100) 0(0) 170(99.4) 1(0.6) 169(98.8) 2(1.2) 159(93.0) 12(7.0) 162(94.7) 9(5.3)
Negative (82) 0(0) 82(100) 0(0) 82(100) 0(0) 82(100) 0(0) 82(100) 0(0) 82(100)
doi:10.1371/journal.pone.0064353.t001
Four Rapid Tests for Vivax Malaria Diagnosis
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method similar to CareStartTM. However, sample buffer was
supplied in a stock bottle and was not included in each package of
test cassettes.
NanoSign Malaria P.f/P.v (Bioland, Korea), a device-type test
with one capture line specific for P. falciparum (aldolase detection)
and a second line that detected all Plasmodium species (pan-pLDH
antigen).
Asan Easy TestH malaria P.f/P.v strip (Asan Pharmaceutical,
Korea), 48 packed strip kits used PfLDH antigen (for P. falciparum)
and Pvaldolase (for P. vivax).
The laboratory performance of the CareStartTM Malaria HRP/
pLDH, the SD Bioline Ag P.f/pan Rapid, and the NanoSign
Malaria P.f/P.v tests has been evaluated by the WHO/FIND
product testing program and results are available on the website
(see above) [14].
Test results were recorded as negative if only a control band
appeared. The presence of a control and test line indicated a
parasite positive result. The test was considered invalid when a
control band did not appear. RDT results were recorded by
different technicians, but each sample was blinded against the
results from the other diagnostic techniques and RDTs.
Microscopic examinations
Microscopic examination was performed on 253 blood samples
collected from vivax malaria patients (n = 171) and from healthy
volunteers (n = 82). The 171 blood samples from patients with
malaria symptoms were first examined microscopically at local
health centers. In addition, blood smear slides for 62 of these
samples were also obtained from local health centers or prepared
at the KCDC for further quantitative study. Eighty-two samples
from healthy volunteers were confirmed as malaria negative at the
KCDC. Thick blood smears were prepared, dried, stained with
10% Giemsa, and examined microscopically. A slide was
considered negative if no asexual stage of Plasmodium spp. were
found during examination of 100 fields. Parasite densities were
assessed by counting against 200 leucocytes, converting to
parasites per microliter by assuming a standard leucocyte count
of 8000/ml. Two technicians counted the parasites under study-
blinded conditions.
Table 2. Sensitivity, specificity and kappa value for rapid diagnostic tests relative to microscopy or nested-PCR for the detection of
Plasmodium vivax.
RDT vs. PCR or Microscopy Sensitivity (95%CI) Specificity (95%CI) Concordance (%) Kappa value *
CareStartTM 99.4 (96.3–100) 100 (94.4–100) 99.4 0.991
SD Bioline 98.8 (95.4–99.8) 100 (94.4–100) 99.2 0.982
NanoSign 93.0 (87.8–96.2) 100 (94.4–100) 95.3 0.896
Asan Easy 94.7 (89.9–97.4) 100 (94.4–100) 96.4 0.921
All cases (n = 256).
CI: confidence interval.
*The strength of agreement between each RDT and nested-PCR or microscopic examination: fair (0.41–0.60), moderate (0.61–0.80), and substantial ($ 0.81).
doi:10.1371/journal.pone.0064353.t002
Figure 2. Correlation between intensity of the positive band of four rapid diagnostic tests (CareStartTM, SD Bioline, NanoSign, and
Asan Easy) and parasitemia (determined by count of thick blood smears). ***; If the strength of positive line is greater than that of control
line (Control line , Positive line), **; If the strength of the positive line is similar to the control line (Control line = Positive line), *; If the strength of
the positive line is less than the control line (Control line . Positive line).
doi:10.1371/journal.pone.0064353.g002
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Nested polymerase chain reaction (Nested PCR)
Nested PCR amplification based on the 18S rRNA gene was
performed for all blood samples as described by Snounou et al.
[15] with slight modification. Using a DNA Mini kit (Qiagen,
USA), genomic DNA was extracted from 200 ml of whole blood
and was suspended in 200 ml of distilled water. Two microliters of
DNA sample was added to a 18 ml master mixture containing 1 ml
premix, 1 ml each primer (rPLU5 and rPLU6), and 15 ml distilled
water. The PCR cycling conditions were: initial denaturation at
94uC for 5 min, 25 cycles of denaturation at 94uC for 30 sec,
annealing at 60uC for 1 min, and extension at 72uC for 1 min.
Two microliters of the first PCR product was used as a template
for a nested PCR (internal primers rVIV1 and rVIV2). The
nested-PCR cycling conditions were: initial denaturation at 92uC
for 5 min, 25 cycles of denaturation at 92uC for 20 sec, annealing
at 52uC for 20 sec, and extension at 78uC for 20 sec. The PCR
products were resolved by electrophoresis on a 2% agarose gel,
stained with ethidium bromide, and visualized with ultraviolet
illumination.
Data analysis
Estimates of sensitivity, specificity, and kappa were calculated
with DAG_Stat and VassarStats (http://vassarstats.net/) [16].
Nested-PCR and microscopic examination results were used as the
reference standard to estimate sensitivity and specificity, together
with their 95% confidence intervals (CI) for the CareStartTM, SD
malaria, NanoSign, and Asan Easy tests. The following kappa
values were used to categorize the strength of agreement between
the each RDT and nested-PCR and microscopic examination: fair
(0.40 to 0.61), moderate (0.61 to 0.80), and substantial (.0.8).
Whenever possible, Standards for the Reporting of Diagnostic
Accuracy (STARD) guidelines were considered during preparation
of this report [17].
Quantitative performance of four RDTs
Blood samples from 62 patients whose parasite densities were
determined by quantification of thick smears were used to assess
the quantitative performance of the four RDTs. The positive
(sample) line was divided into three groups depending on the ratio
of the test line intensity compared to control line intensity (*:
positive line , control line; **: positive line = control line; ***:
positive line . control line). Three technicians read line intensity
for all RDTs under conditions in which each sample was blinded
against the results from the other diagnostic techniques. These
results were compared with parasite counts obtained by thick
smear. To facilitate ease of comparison, samples were divided into
five groups based on the parasite densities: (1–150; 151–500; 501–
1000; 1001–5000; .5000/ml).
Results
Diagnostic performance of four RDTs, nested PCR, and
microscopic examination
Two hundred and fifty-three blood samples obtained from the
malaria patients diagnosed at local health centers and healthy
subjects were examined with the nested PCR and microscopy.
One hundred and seventy-one of these samples tested positive for
vivax malaria. The 82 healthy individuals tested negative for P.
vivax (nested PCR; Table 1). The 171 vivax malaria positive
samples were tested with each of the four RDTs; 170, 169, 159,
and 162 of them were vivax malaria positive with the
CareStartTM, SD Bioline, NanoSign, and Asan Easy tests,
respectively. Results from the four RDTs for the 82 samples from
healthy people were negative (Table 1).
Sensitivity, specificity, and kappa value of four RDTs
RDT sensitivity and specificity were calculated using micro-
scopic examination as the reference test. Sensitivity of the
CareStartTM (99.4%, CI: 96.3–100) and SD Bioline (98.8%, CI:
95.4–99.8) tests were greater than the sensitivities of the NanoSign
(93.0%, CI: 87.8–96.2) and Asan Easy (94.7%, CI: 89.9–97.4)
tests. Specificity was 100% (CI: 94.4–100) for all of the RDTs.
Test agreement was calculated by comparing RDT results with
microscopic examination. All RDTs showed high agreements
(concordance: 95.3–99.4%, kappa value: 0.896–0.991) with
microscopic examination (Table 2).
Quantitative performance of CareStartTM
To determine whether the RDTs could detect low numbers of
P. vivax, results for each sample were categorized according to
parasite density. The 62 samples that were shipped with blood
smears slides or prepared within 6 hours after blood collection
were used for this evaluation. CareStartTM and SD Bioline tests
could detect P. vivax at low parasite densities (sensitivity: 100%),
the NanoSign test had a low sensitivity (60%) at a parasite density
of 1–150/ml. We wondered whether we could use RDTs to
quantify the parasite load in the patient by comparing the ratio of
test to control band intensity. Therefore, the ratio of test to control
band intensity for the four RDTs was compared to corresponding
parasitemia. There was a slight positive correlation between the
ratio of the test to control band density for each RDT and the
parasitemia counts (Fig. 2).
Discussion
The WHO recommends microscopic examination as the gold
standard for P. vivax malaria diagnosis. Physicians at local health
centers still use this method, but have asked which of the RDTs is
most accurate for diagnosis of this disease. In the Korean market,
RDTs vary in price from US $4.40 to 6.60 per test, much more
expensive when compared with the cost of these tests in other
countries [14]. In this study, we compared the diagnostic
performance of four RDTs relative to microscopic examination
and nested-PCR to help physicians make an informed choice
when selecting an RDT.
In the current study, CareStartTM, SD Bioline, NanoSign and
Asan Easy, which are all currently used in South Korea, were
selected for diagnosis of malaria caused P. vivax. In Round four of
Table 3. Diagnostic performances of four rapid diagnostic
tests compared with microscopic examination for various
Plasmodium vivax parasite densities.
No. of
patientsNo. of positive (Sensitivity%)
Care
StartTM
SD
Bioline
Nano
Sign
Asan
Easy
. 5000/ml 14 14 (100) 14 (100) 14 (100) 14 (100)
1001–5000/ml 23 23 (100) 23 (100) 23 (100) 23 (100)
501–1000/ml 9 9 (100) 9 (100) 9 (100) 9 (100)
151–500/ml 11 11 (100) 11 (100) 10 (90.9) 10 (90.9)
1–150/ml 5 5 (100) 5 (100) 3 (60.0) 5 (100)
Total 62 62 (100) 62 (100) 59 (95.2) 61 (98.4)
doi:10.1371/journal.pone.0064353.t003
Four Rapid Tests for Vivax Malaria Diagnosis
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the WHO/FIND study, CareStartTM and SD Bioline had high
panel detection score for the diagnosis of vivax malaria at 94.1 and
97.1, respectively, when at least 200 parasites/ml were present.
Few efficacy studies of NanoSign or Asan Easy test performance
have been conducted, so the current study compared their
performance with CareStartTM and SD Bioline test. Vivax
malaria is the only indigenous malaria in South Korea, and
accounts for 99.9% of all cases without any history of travel abroad
[18]. Therefore, although the pan-LDH line used in CareStartTM
and SD Bioline tests indicates the presence of at least one of three
Plasmodium species (P. vivax, P. malariae, P. ovale), a definite pan-
LDH line in samples from patients without a travel history to
foreign countries could, at least initially, be considered to be vivax
malaria positive.
As shown in Table 1, no case of plasmodium malaria was
observed in 171 samples because the samples were collected near
Demilitarized Zone (DMZ) regions where indigenous vivax
malaria normally occurs. The sensitivities and specificities of the
RDTs were higher than estimates from previous studies [9,19]. In
particular, sensitivities of the CareStartTM and SD Bioline tests
(99.4 and 98.8%, respectively) estimated by the present study were
higher than previously reported by a hospital-based study in South
Korea (95.5 and 92.7%, respectively) [19]. The difference may
have resulted from the type of samples used in each study. In
contrast with the present study, the previous study used frozen
samples. Overall, the performance of the CareStartTM and SD
Bioline tests appears to be similar to microscopic examination and
nested-PCR, which suggests that these RDTs could be used as
alternative diagnostic tools for P. vivax detection. However, except
for P. falciparum, these RDTs cannot differentiate Plasmodium
species, which is disadvantageous for the diagnosis of imported
malaria cases. Thus, we recommend that nested PCR should be
performed after a positive CareStartTM or SD Bioline test result to
confirm and differentiate the Plasmodium species. These RDTs
could be used for malaria screening and diagnosis at local health
centers. When appropriate, samples could be sent to a laboratory
with PCR capability for further diagnosis.
Because transmission rates and parasite densities in South
Korea vivax malaria patients are usually low, a high RDT
sensitivity is very important. As shown in Table 3, the four RDTs
could detect vivax malaria in all samples at a concentration of
.501/ml parasite density; however, each 3 and 1 vivax malaria
samples were negative for the NanoSign and Asan Easy tests at a
concentration of ,500/ml parasite density. Although it is difficult
to compare studies because of differences in parasite density,
sensitivities of the CareStartTM and SD Bioline tests at ,150/ml
parasite density (both 100%) were higher than previously reported
[19]. Because there were a limited number of low parasitemia
(,150/ml) samples in this study, additional studies would be
required to confirm this result. Furthermore, additional quantita-
tive study could be helpful for clinicians who would like to know
the parasite load without preparing blood smears. As shown in
Fig. 2, there was a slight correlation between parasite densities and
the ratio of the test to control band density. However, there were
many samples with high parasite densities but a smaller ratio (* in
Fig. 2). Health center personnel could estimate the parasite load
based on this ratio of the thickness of the control and test lines, but
this estimate should be confirmed by microscopic examination for
exact counting.
The malaria endemic regions of South Korea are restricted to
near DMZ. Thus, 50% of patients are soldiers and discharged
soldiers [18]. Some local areas, including some army camps in
South Korea, have limited special staff trained to perform time-
consuming microscopic diagnosis from examination of thick and
thin smears. Use of RDTs could shorten the time to diagnosis.
Continuous product testing is necessary to guide personnel at
local health centers and to improve RDT quality. The KCDC
intended to summarize published data, including this study, to
guide procurement decisions made by personnel at local health
centers and hospitals in South Korea. Further, accurate and rapid
malaria diagnosis may help to prevent secondary transmission in
other countries. This study is expected to help improve the
accuracy of malaria diagnosis in the field, especially under
conditions of low parasitemia, and to assist with diagnostic
method procurement decisions.
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